Disclosure information not submitted.
Competing Outcomes With Ivabradine Therapy In HFrEF: EHR Based Observational Study
Monday, March 9, 2026
10:51 AM - 10:57 AM EST
Sglt2 Inhibitors In Heart Failure: Are All Agents Equal In Safety And Efficacy?
Monday, March 9, 2026
10:57 AM - 11:03 AM EST
Comparative Outcomes Of Glp‑1 Ras And Sglt2 Inhibitors In Heart Failure Patients With T2dm
Monday, March 9, 2026
11:09 AM - 11:15 AM EST